NCT00001339View on ClinicalTrials.gov

A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 31, 1993

Study Completion Date

August 31, 2002

Conditions
Adrenal Cortical Carcinoma
Interventions
DRUG

doxorubicin, vincristine, and etoposide with mitotane

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH